Managing Hyperglycemia in Patients With Cushing’s Disease Treated With Pasireotide: Medical Expert Recommendations

Pituitary- Netherlands

doi 10.1007/s11102-013-0483-3

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

The Medical Treatment With Pasireotide in Cushing’s Disease: An Italian Multicentre Experience Based on “Real-World Evidence”

Endocrine
2019English

Monitoring Patient Improvement Parameters Following Pasireotide Treatment in Cushing’s Disease

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2013English

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

Pituitary
EndocrinologyMetabolismDiabetes
2019English

Managing Hyperglycemia in Acute Ischemic Stroke Patients

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Update on Medical Treatment for Cushing’s Disease

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Hyperglycemia and Mortality Among Patients With Coronary Artery Disease

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

Erratum To: The Treatment With Pasireotide in Cushing’s Disease: Effects of Long–term Treatment on Tumor Mass in the Experience of a Single Center

Endocrine
2016English

A Prospective Study of Appetite and Food Craving in 30 Patients With Cushing’s Disease

Pituitary
EndocrinologyMetabolismDiabetes
2015English

Managing Cardiovascular Disease Risk in Patients With Severe Mental Illness

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy